Animal cloning and the FDA-the risk assessment paradigm under public scrutiny

Animal cloning and the FDA-the risk assessment paradigm under public scrutiny

The evidence gathered thus far—ultimately to be published in the Draft Risk Assessment on Animal Cloning—indicates that there are no unique risks associated with animal cloning.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature biotechnology 2007-01, Vol.25 (1), p.39-43
Hauptverfasser: Rudenko, Larisa, Matheson, John C, Sundlof, Stephen F
Format: Artikel
Sprache:eng
Schlagworte:
Agriculture
Animals
Bioinformatics
Biomedical and Life Sciences
Biomedical Engineering/Biotechnology
Biomedicine
Biotechnology
Cloning
Cloning, Organism
commentary
Consumer Product Safety
Food, Genetically Modified
Government Regulation
Life Sciences
Organisms, Genetically Modified
Public Opinion
Risk assessment
Risk Assessment - methods
Risk Factors
United States
United States Food and Drug Administration
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The evidence gathered thus far—ultimately to be published in the Draft Risk Assessment on Animal Cloning—indicates that there are no unique risks associated with animal cloning.
ISSN:1087-0156
1546-1696
DOI:10.1038/nbt0107-39